June 2011 Archives

June 30, 2011

Valproate During Pregnancy Increases Risk of Impaired Cognitive Development in Newborn (6.30.11)

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics

To report complications resulting from Valproate:

For more detailed information on this, go to: Valproate Products: Drug Safety Communication - Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)
June 24, 2011

Selenium May Reduce Risk of Cancer (6.24.11)

According to multiple studies, Selenium may reduce the risk of cancer, particularly in men. Data indicate that those with higher levels of Selenium tend to have a decreased incidence of cancer. Selenium for preventing cancer

June 20, 2011

Olive Reduces Risk of Strokes (6.20.11)

Not only is olive oil beneficial for your heart, it also reduces your risk of having a stroke, according to recent study in France. The study shows that using olive oil for cooking and on salads can result in greater than a 40% decrease in strokes.

Olive Oil Protects Against Stroke

June 16, 2011

Cervical Length Ultrasound Measurements Cost-Effective Means Detecting Preterm Birth (6.16.11)

Utilizing cervical length ultrasound screening on all pregnant women appears to be a cost-effective and reliable way to screen for pregnancies at risk of preterm delivery.

Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis

June 15, 2011

Actos Increases Risk of Bladder Cancer (6.15.11)

After two European counties banned Actos, the FDA now warns that Actos increases the risk of bladder cancer in patients who have been taking the drug for more than one year.

FDA Warns of Bladder Cancer Risk With Actos

June 15, 2011

Sleeping Supine (on back) May Increase Risk of Stillbirth (6.15.11)

According to recent study in New Zealand, pregnant women (at least 28 weeks' gestation) who slept supine the last night of their pregnancy experienced a two-fold increase in stillbirth. It is believed that this position compromises fetal oxygenation. The study also noted that pregnant women should sleep on their left side to decreases risks to their unborn baby. Association between maternal sleep practices and risk of late stillbirth: a case-control study

June 9, 2011

Proscar and Avodart Associated with Increased Risk of Prostate Cancer (6.9.11)

According to the FDA, Proscar and Avodart, used to treat benign prostatic hypertrophy (enlarged prostate gland), increases the risk of high-grade prostate cancer. Although the risk is considered low, the labeling is being updated to reflect these new findings

FDA Warns of High-Grade Prostate Ca Risk with BPH Drugs

June 9, 2011

Zocor (simvastatin) 80mg Increases Risk of Muscle Damage (6.9.11)

According to the FDA the cholesterol-lowering medication simvastatin 80 mg increases the risk of muscle damage (myopathy). Lower doses, however, are not associate with an increased risk of myopathy.
For additional information, go to: Zocor (simvastatin): Label Change - New Restrictions, Contraindications, and Dose Limitations

June 7, 2011

CT Angiography Effective In Predicting Coronary Risks (6.7.11)

CTA's are now very useful in predicting coronary risks. According to study data, patients who were found to have one or more significant stenoses had a nearly ten-fold increased risk of experiencing coronary complications.

Primary source: Journal of the American College of Cardiology
Source reference:

Meta-Analysis and Systematic Review of the Long-Term Predictive Value of Assessment of Coronary Atherosclerosis by Contrast-Enhanced Coronary Computed Tomography Angiography

June 7, 2011

Supplementing Chemotherapy with Avastin May Prolong Survival in Ovarian Cancer Patients (6.7.11)

Recent study data show that patients undergoing chemotherapy for ovarian cancer reduced their risk of death by as much as 36% when supplementing their treatment with Avastin.

http://www.medpagetoday.com/MeetingCoverage/ASCO/26865?utm_source=share&utm_medium=mobile&utm_campaign=medpage%252Biphone%2520app

June 7, 2011

CO2 FilterLine H Set Infant/Neonate & VitaLine H Set Infant/Neonate Have Plastic Strands on Adapter that May Dislodge Into Infant's/Neonate's Lungs (6.7.11)

According to the FDA, there are fine plastic strands on the inner surface of the infant/neonatal airway adapter may become dislodged and aspirated by the infant/neonate resulting in serous respiratory complications.
For additional information, go to: Oridion Medical and Philips Healthcare Microstream CO2 Filterline (FilterLine H Set Infant/Neonate, VitaLine H Set Infant/Neonate: Recall - Plastic Strands on the Adapter May Become Dislodged, Inhaled by Patient